DBD stock: buy or sell?

DBD stock price: $11.58 -7.66% At close on August 23rd, 2019

Updated on:
August 23rd, 2019


Diebold Nixdorf plummed a scary -7.66% and closed at $11.58.

Diebold Nixdorf, Incorporated provides connected commerce services, software, and technology for financial, commercial, and industrial customers.

Should I buy DBD stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Following a trading plan helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with Diebold Nixdorf stock situation right now, therefore this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean DBD will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Diebold Nixdorf stock a buy?

Banks and financial institutions publish stock ratings everyday. At Stocks2.com, we found 1 rating published for DBD stock in the last month.

Is DBD a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-2-14JPMorgan Chase & Co.n/aSell

DBD stock analysis

Daily outlook

Diebold Nixdorf closed today at $11.58 and plummed a scary -7.66%.

Diebold Nixdorf shares plummed -7.66% to $11.58 today. Since April when SMA100d and SMA200d crossed up, DBD price slipped $-0.95 per share (-7.58%). Since July 25th when DBD stock price broke up the SMA100d line, it gained $1.29 (12.54%).

DBD stock chart (daily)

Weekly outlook

Diebold Nixdorf collapsed a scary -7.29% this week. Early August DBD boosted an extraordinary 6.06% in just one week.

In a weekly time frame, Diebold Nixdorf stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, DBD might consolidate in a flat-base, waiting to break out over or down under . Since SMA20d and SMA40w crossed up early April, DBD price climbed $0.51 per share (4.61%). Since mid February when DBD stock price broke up the SMA40w line, it gained $6.57 (131.14%).

DBD stock chart (weekly)

DBD stock price history

DBD IPO was on December 31st, 1981 at $2.07 per share1. Since then, DBD stock surged a 459.40%, with a yearly average of 12.40%. If you had invested $1,000 in DBD stock in 1981, it would worth $4,594.00 today.

1: Adjusted price after possible price splits or reverse-splits.

DBD stock historical price chart

DBD stock reached 52-week highs on July 31st at $14.66, and all-time highs 2005-04-07 with a price of 38.51.

DBD stock price target is $7.00

How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we only found 1 price prediction for Diebold Nixdorf stock:
DBD stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-2-14JPMorgan Chase & Co.Set Price Targetn/a$7.00-
(in average)$0.00$7.000.0%

Financials and fundamental analysis

Earnings date and Earnings per Share

After publishing its last earnings report on February, Diebold Nixdorf . As soon as we get its actual EPS from the earnings report, we will update this review.
DBD earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

In 2018, Diebold Nixdorf annual turnover remained steady a bad -0.67% to $4,578.60 million USD from $4,609.30 marked in 2017. When comparing 2018 vs 2017, on the other hand, profit margin (that is, the net income divided by revenues) dropped a -7.18% to -12.42%.

DBD annual Sales and Income evolution
2013$2,860 M-$-181.61 M-6.3%-
2014$3,051 M6.68%$114 M3.8%-163.00%
2015$2,419 M-20.71%$74 M3.0%-35.59%
2016$3,316 M37.08%$-33.00 M-1.0%-144.78%
2017$4,609 M38.99%$-241.50 M-5.2%631.82%
2018$4,579 M-0.67%$-568.70 M-12.4%135.49%

Quarterly financial results

Diebold Nixdorf reported $1,289.80 million in revenues for 2018-Q4, a 15.26% up compared to previous quarter. Reported quarter earnings marked $-145.50 M with a profit margin of -11.28%. Profit margin escalated a 7.72% compared to previous quarter when profit margin was -19.00%. When comparing sales to same quarter last year, Diebold Nixdorf sales marked a beatiful growth and raised a 3.19%. Looking back to recent quarterly results, Diebold Nixdorf posted 3 negative quarters in a row.
DBD quarterly Sales and Income evolution
2017-Q2$1,130 M-$-30.60 M-2.7%-
2017-Q3$1,123 M-0.65%$-35.40 M-3.2%15.69%
2017-Q4$1,250 M11.33%$-106.40 M-8.5%200.56%
2018-Q1$1,064 M-14.86%$-70.90 M-6.7%-33.36%
2018-Q2$1,106 M3.89%$-138.50 M-12.5%95.35%
2018-Q3$1,119 M1.21%$-212.60 M-19.0%53.50%
2018-Q4$1,290 M15.26%$-145.50 M-11.3%-31.56%
2019-Q1$1,028 M-20.29%$-132.70 M-12.9%-8.80%

Diebold Nixdorf ownership

When you are planning to buy a stock, it's always worth to check its ownership structure.

Diebold Nixdorf shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 2.39% of all shares.

Bearish positions for DBD stock account 0.00%, no big difference from last month.

For a better context understanding, the following table shows ownership data compared to other related companies:

Market cap$886.9 M$3.6 B$3.7 B$356.7 M$652.4 M
Total shares76.6 M49.9 M120.1 M16.3 M180.7 M
Float shares75.8 M48.6 M119.4 M8.7 M179.3 M
  - Institutional holdings (%)99.2%105.1%98.8%59.5%74.1%
  - Insider holdings (%)2.4%1.1%1.3%33.8%0.5%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

DBD summary

Friday, August 23rd, 2019
Day range$11.47 - $12.74
Previous close$12.54
Session gain-7.66%
Average true range$0.75
50d mov avg$11.00
100d mov avg$10.85
200d mov avg$8.28
Daily pattern
Weekly pattern lt06a

Diebold Nixdorf performance

To better understand Diebold Nixdorf performance you must becnhmark its gains with other related stocks in same sector or industry. We compared Diebold Nixdorf against Brink's, NCR, PAR Technology, Pitney Bowes and USA Technologies in the following table:
DBDDiebold Nixdorf25.73%33.72%154.51%
NCR -2.43%5.28%6.94%
PARPAR Technology-18.82%-19.66%-5.59%
PBIPitney Bowes-21.01%-52.93%-52.87%
USATUSA Technologies15.57%100.00%-47.01%

Diebold Nixdorf competitors

One check before investing in any stock is to review a list of its competitors, in this case for Diebold Nixdorf. We chose 5 companies as Diebold Nixdorf competitors as they are in the same industry or have similar market objectives.